|Articles|June 24, 2013

News from DIA 2013

News and Updates from DIA 2013

BBK Worldwide Mobilizes 7,000 Attendees of the Drug Information Association Annual Meeting to Be "Boston Strong"

IMS Greenphire Demo eClinicalGPS and GrantPlan Integration

Exco InTouch Unveils New Website and Program for DIA 2013 49th Annual Meeting

LabConnect to Showcase Innovative Ambient Sample Shipping System at DIA

Virtify Will be Making a $5 Contribution to the The One Fund Boston for Each Visitor to Their Booth

SynteractHCR Launches Intelligent Clinical Development Platform at DIA 2013 to Support Trial Efficiencies Globally

Australian CRO Novotech Announces Expanded Asia Reach into Hong Kong and Philippines at DIA 2013

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

News from DIA 2013

Related Content

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

How to Tell Substance from Branding in Biotech's Support Ecosystem

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap